Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

Autor: Gelfand JM, Wan J, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF Jr, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS

Publikováno v: Archives of Dermatology; Apr2012, Vol. 148 Issue 4, p487-494, 8p

In response to 'Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?'.

Autor: Frankel A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl M, Bebo BF Jr, Gottlieb A

Publikováno v: Journal of the American Academy of Dermatology; Apr2011, Vol. 64 Issue 4, p788-790, 3p

The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.

Autor: Bebo BF Jr; National Multiple Sclerosis Society, New York, NY, USA., Banwell BL; Division of Child Neurology, Children's Hospital of Philadelphia, Departments of Neurology and Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Whitacre CC; National Multiple Sclerosis Society, New York, NY, USA., Coetzee T; National Multiple Sclerosis Society, New York, NY, USA., Dalgas U; Exercise Biology, Department of Public Health, Aarhus University, Aarhus, Denmark., De Jager PL; Center for Translational and Computational Neuroimmunology, Department of Neurology, Columbia University, New York, NY, USA., Proebstel AK; Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Neurology, Biomedicine, and Clinical Research, University Hospital Basel, Basel, Switzerland., Yong VW; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada., Benveniste EN; Department of Cell, Developmental and Integrative Biology, The University of Alabama at Birmingham, Birmingham, AL, USA., Thompson AJ; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, NIHR University College London Hospitals Biomedical Research Centre, Faculty of Brain Sciences, University College London, London, UK.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Sep; Vol. 30 (10), pp. 1242-1251. Date of Electronic Publication: 2024 Aug 30.

Landscape of MS patient cohorts and registries: Recommendations for maximizing impact.

Autor: Bebo BF Jr; National Multiple Sclerosis Society, New York, NY, USA., Fox RJ; Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA., Lee K; Multiple Sclerosis Society of Canada, Toronto, ON, Canada., Utz U; Division of Extramural Research, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, Bethesda, MD, USA., Thompson AJ; Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2018 Apr; Vol. 24 (5), pp. 579-586. Date of Electronic Publication: 2017 Mar 01.

Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.

Autor: Abuabara K; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA., Wan J, Troxel AB, Shin DB, Van Voorhees AS, Bebo BF Jr, Krueger GG, Callis Duffin K, Gelfand JM

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2013 Feb; Vol. 68 (2), pp. 262-9. Date of Electronic Publication: 2012 Aug 19.